12.94
前日終値:
$13.09
開ける:
$13.09
24時間の取引高:
1.69M
Relative Volume:
0.54
時価総額:
$965.96M
収益:
$65,400
当期純損益:
$-46.34M
株価収益率:
-14.07
EPS:
-0.92
ネットキャッシュフロー:
$-38.74M
1週間 パフォーマンス:
+4.35%
1か月 パフォーマンス:
+12.52%
6か月 パフォーマンス:
+17.96%
1年 パフォーマンス:
+88.63%
CorMedix Inc Stock (CRMD) Company Profile
名前
CorMedix Inc
セクター
電話
908-517-9500
住所
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CRMD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CRMD
CorMedix Inc
|
12.94 | 954.76M | 65,400 | -46.34M | -38.74M | -0.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-30 | ダウングレード | D. Boral Capital | Buy → Hold |
2025-06-30 | 開始されました | H.C. Wainwright | Buy |
2025-03-07 | 開始されました | Leerink Partners | Outperform |
2025-01-13 | 開始されました | D. Boral Capital | Buy |
2024-08-26 | 開始されました | Rodman & Renshaw | Buy |
2023-08-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-02-17 | 開始されました | Needham | Buy |
2020-09-29 | 開始されました | JMP Securities | Mkt Outperform |
2020-09-21 | 開始されました | Truist | Buy |
2019-12-18 | 開始されました | B. Riley FBR | Buy |
2019-03-26 | 繰り返されました | H.C. Wainwright | Buy |
2018-12-06 | 開始されました | ROTH Capital | Buy |
2017-09-25 | 繰り返されました | H.C. Wainwright | Buy |
2017-08-10 | 繰り返されました | Rodman & Renshaw | Buy |
2017-05-05 | 繰り返されました | Rodman & Renshaw | Buy |
2016-11-11 | 繰り返されました | FBR & Co. | Outperform |
2016-03-17 | 繰り返されました | FBR Capital | Outperform |
2016-03-03 | 開始されました | FBR Capital | Outperform |
2015-11-16 | 繰り返されました | ROTH Capital | Neutral |
2015-10-29 | 繰り返されました | ROTH Capital | Neutral |
2015-05-06 | ダウングレード | ROTH Capital | Buy → Neutral |
2014-12-08 | 繰り返されました | ROTH Capital | Buy |
2011-10-03 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
CorMedix Inc (CRMD) 最新ニュース
Cormedix CEO Todisco sells $650,000 in shares - Investing.com
CorMedix Inc. Stock (CRMD) Opinions on Recent Analyst Rating Upgrade - Quiver Quantitative
Cormedix COO Hurlburt sells $711k in shares By Investing.com - Investing.com Canada
Cormedix COO Hurlburt sells $711k in shares - Investing.com
Zelnick Kaufman, chief legal officer at CorMedix, sells $670k in shares - Investing.com
Needham Maintains a Buy Rating on CorMedix (CRMD) With a $20 PT - MSN
TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA - The Globe and Mail
CorMedix Completes Acquisition of Melinta Therapeutics - MSN
CorMedix (CRMD) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - sharewise.com
CorMedix makes $5M minority equity investment in Talphera - MSN
CorMedix stock investment in Talphera adds pipeline optionality, JMP reiterates By Investing.com - Investing.com
Talphera Announces $29 Mln Private Placement Led By CorMedix And Institutional Investors - Nasdaq
Order Flow Trends Show Accumulation in CorMedix Inc.July 2025 Movers & Weekly Breakout Stock Alerts - beatles.ru
Will CorMedix Inc. stock hit new highs in YEARMarket Sentiment Review & Reliable Momentum Entry Alerts - 뉴스영
Talphera Secures Up To $29 Mln In Private Placement Led By CorMedix - Nasdaq
Short Term Charts Align With Long Term Uptrend in CorMedix Inc.Weekly Trading Summary & Free Safe Capital Growth Stock Tips - beatles.ru
What makes CorMedix Inc. stock attractive todayJuly 2025 Selloffs & Safe Capital Growth Trade Ideas - beatles.ru
Should you buy the dip on CorMedix Inc.2025 Market Outlook & Stepwise Entry/Exit Trade Alerts - beatles.ru
CorMedix leads $29 million financing round in Talphera By Investing.com - Investing.com Canada
CorMedix leads $29 million financing round in Talphera - Investing.com
CorMedix Backs Talphera With $5 Million Investment And Board Seat - Finimize
CorMedix Invests $5 Million in Talphera - MarketScreener
CorMedix Inc. Makes $5 Million Strategic Investment in Talphera, Inc. to Support Development of Niyad™ - Quiver Quantitative
CorMedix announces strategic minority investment in Talphera - MarketScreener
$5M Strategic Investment: CorMedix Secures First Rights to Acquire Talphera's Breakthrough CRRT Drug - Stock Titan
CorMedix : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - MarketScreener
Is CorMedix Inc. stock a smart retirement pickExit Point & Free Real-Time Market Sentiment Alerts - beatles.ru
Talphera, Inc. announced that it expects to receive $29 million in funding from CorMedix Inc., Nantahala Capital Management, LLC, Rosalind Advisors, Inc. and other investors - MarketScreener
Can CorMedix Inc. withstand a market correctionEntry Point & Daily Profit Maximizing Trade Tips - classian.co.kr
Is CorMedix Inc. backed by strong institutional buyingProduct Launch & Entry Point Confirmation Signals - خودرو بانک
When is the best time to exit CorMedix Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
CorMedix at Cantor Global Healthcare Conference: Strategic Growth and Diversification - Investing.com Australia
Will CorMedix Inc. benefit from current market trendsWeekly Stock Report & AI Optimized Trading Strategy Guides - خودرو بانک
CorMedix at Cantor Global Healthcare Conference: Strategic Growth and Diversification By Investing.com - Investing.com South Africa
Using RSI to spot recovery in CorMedix Inc.July 2025 WrapUp & Weekly Watchlist of Top Performers - Newser
Real time pattern detection on CorMedix Inc. stock2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - Newser
Can trapped investors hope for a rebound in CorMedix Inc.July 2025 WrapUp & Verified Chart Pattern Signals - Newser
Comparing CorMedix Inc. in custom built stock radars2025 Bull vs Bear & Short-Term Trading Alerts - Newser
Deerfield Management Sells Melinta Therapeutics To CorMedix - citybiz
Is CorMedix Inc. showing signs of accumulationJuly 2025 Outlook & Stock Portfolio Risk Management - Newser
Cormedix Inc. shares fall 1.05% premarket after presenting at Cantor and Morgan Stanley conferences. - AInvest
How high can CorMedix Inc. stock goJuly 2025 Recap & Expert Curated Trade Ideas - Newser
What the charts say about CorMedix Inc. todayWeekly Trend Recap & Daily Profit Maximizing Trade Tips - Newser
Cormedix (CRMD) Gets a Buy from Truist Financial - The Globe and Mail
CorMedix to Participate in Upcoming Investor Conferences - 富途牛牛
Cormedix (CRMD) Gets a Buy from RBC Capital - The Globe and Mail
Sentiment analysis tools applied to CorMedix Inc.2025 Dividend Review & Free Community Consensus Stock Picks - Newser
Statistical indicators supporting CorMedix Inc.’s strengthProduct Launch & Comprehensive Market Scan Reports - Newser
Institutional Confidence Rises as CorMedix Inc. (CRMD) Hits Profitability - MSN
Analyzing CorMedix Inc. with multi timeframe charts2025 Key Highlights & Entry Point Confirmation Alerts - Newser
CorMedix Inc.’s volatility index tracking explainedBull Run & Free Long-Term Investment Growth Plans - Newser
CorMedix Inc (CRMD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):